SAN FRANCISCO — Two weeks into a jury trial between Onyx and Bayer over a cancer drug, the pharmaceutical companies have settled. But the teams of litigators don’t get to take credit.

While lawyers from Cooley’s Bay Area offices, representing Onyx, and Morrison & Foerster and Chicago’s Bartlit Beck Herman Palenchar & Scott, for Bayer, were burning the midnight oil in trial, business-side lawyers were involved in their own ’round-the-clock negotiations.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]